Is NRXS or CLPT more profitable?

ClearPoint Neuro has a net margin of -71.57% compared to NeurAxis' net margin of -492.76%. NeurAxis' return on equity of 0.00% beat ClearPoint Neuro's return on equity. Company Net Margins Return on Equity Return on Assets NeurAxis -492.76% N/A -641.25% ClearPoint Neuro -71.57% -140.96% -36.98%

Is NRXS or CV more profitable?

CapsoVision has a net margin of -198.87% compared to NeurAxis' net margin of -492.76%. Company Net Margins Return on Equity Return on Assets NeurAxis -492.76% N/A -641.25% CapsoVision -198.87% N/A -136.03%

Is CARL or NRXS more profitable?

Carlsmed has a net margin of -57.76% compared to NeurAxis' net margin of -492.76%. NeurAxis' return on equity of 0.00% beat Carlsmed's return on equity. Company Net Margins Return on Equity Return on Assets Carlsmed -57.76% -60.74% -29.84% NeurAxis -492.76% N/A -641.25%

Which has preferable valuation and earnings, NRXS or ELMD?

Electromed has higher revenue and earnings than NeurAxis. NeurAxis is trading at a lower price-to-earnings ratio than Electromed, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio NeurAxis $4.28M 20.39 -$14.63M -$0.81 N/A Electromed $71.75M 4.16 $5.15M $1.17 30.82

Is NRXS or ELMD more profitable?

Electromed has a net margin of 11.34% compared to NeurAxis' net margin of -492.76%. Electromed's return on equity of 15.71% beat NeurAxis' return on equity. Company Net Margins Return on Equity Return on Assets NeurAxis -492.76% N/A -641.25% Electromed 11.34% 15.71% 13.37%

NeurAxis (NRXS) Competitors

$7.05 +0.04 (+0.54%)

As of 02:52 PM Eastern

Compare

NRXS vs. CLPT, CV, CARL, ELMD, and SI

Should you buy NeurAxis stock or one of its competitors? MarketBeat compares NeurAxis with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with NeurAxis include ClearPoint Neuro (CLPT), CapsoVision (CV), Carlsmed (CARL), Electromed (ELMD), and Shoulder Innovations (SI). These companies are all part of the "medical equipment" industry.

How does NeurAxis compare to ClearPoint Neuro?

NeurAxis (NASDAQ:NRXS) and ClearPoint Neuro (NASDAQ:CLPT) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, valuation, dividends, institutional ownership, risk, earnings, analyst recommendations and media sentiment.

ClearPoint Neuro has a net margin of -71.57% compared to NeurAxis' net margin of -492.76%. NeurAxis' return on equity of 0.00% beat ClearPoint Neuro's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
NeurAxis	-492.76%	N/A	-641.25%
ClearPoint Neuro	-71.57%	-140.96%	-36.98%

11.8% of NeurAxis shares are held by institutional investors. Comparatively, 30.1% of ClearPoint Neuro shares are held by institutional investors. 21.1% of NeurAxis shares are held by insiders. Comparatively, 6.9% of ClearPoint Neuro shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

NeurAxis presently has a consensus price target of $13.00, indicating a potential upside of 84.45%. ClearPoint Neuro has a consensus price target of $18.00, indicating a potential upside of 35.41%. Given NeurAxis' stronger consensus rating and higher probable upside, equities analysts clearly believe NeurAxis is more favorable than ClearPoint Neuro.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NeurAxis	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
ClearPoint Neuro	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

In the previous week, ClearPoint Neuro had 6 more articles in the media than NeurAxis. MarketBeat recorded 6 mentions for ClearPoint Neuro and 0 mentions for NeurAxis. ClearPoint Neuro's average media sentiment score of 0.31 beat NeurAxis' score of 0.00 indicating that ClearPoint Neuro is being referred to more favorably in the news media.

Company	Overall Sentiment
NeurAxis	Neutral
ClearPoint Neuro	Neutral

NeurAxis has higher earnings, but lower revenue than ClearPoint Neuro. ClearPoint Neuro is trading at a lower price-to-earnings ratio than NeurAxis, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NeurAxis	$4.28M	20.39	-$14.63M	-$0.81	N/A
ClearPoint Neuro	$36.97M	10.78	-$25.54M	-$1.01	N/A

NeurAxis has a beta of 1.42, meaning that its share price is 42% more volatile than the broader market. Comparatively, ClearPoint Neuro has a beta of 1.31, meaning that its share price is 31% more volatile than the broader market.

Summary

NeurAxis beats ClearPoint Neuro on 9 of the 16 factors compared between the two stocks.

How does NeurAxis compare to CapsoVision?

NeurAxis (NASDAQ:NRXS) and CapsoVision (NASDAQ:CV) are both small-cap medical equipment companies, but which is the better investment? We will compare the two companies based on the strength of their valuation, institutional ownership, profitability, earnings, media sentiment, dividends, risk and analyst recommendations.

11.8% of NeurAxis shares are held by institutional investors. 21.1% of NeurAxis shares are held by company insiders. Comparatively, 2.3% of CapsoVision shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

NeurAxis presently has a consensus price target of $13.00, suggesting a potential upside of 84.45%. CapsoVision has a consensus price target of $8.50, suggesting a potential upside of 26.21%. Given NeurAxis' stronger consensus rating and higher possible upside, analysts plainly believe NeurAxis is more favorable than CapsoVision.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NeurAxis	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
CapsoVision	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50

In the previous week, CapsoVision had 1 more articles in the media than NeurAxis. MarketBeat recorded 1 mentions for CapsoVision and 0 mentions for NeurAxis. CapsoVision's average media sentiment score of 1.87 beat NeurAxis' score of 0.00 indicating that CapsoVision is being referred to more favorably in the news media.

Company	Overall Sentiment
NeurAxis	Neutral
CapsoVision	Very Positive

NeurAxis has higher earnings, but lower revenue than CapsoVision. NeurAxis is trading at a lower price-to-earnings ratio than CapsoVision, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NeurAxis	$4.28M	20.39	-$14.63M	-$0.81	N/A
CapsoVision	$13.55M	24.83	-$25.32M	-$2.34	N/A

CapsoVision has a net margin of -198.87% compared to NeurAxis' net margin of -492.76%.

Company	Net Margins	Return on Equity	Return on Assets
NeurAxis	-492.76%	N/A	-641.25%
CapsoVision	-198.87%	N/A	-136.03%

Summary

CapsoVision beats NeurAxis on 8 of the 14 factors compared between the two stocks.

How does NeurAxis compare to Carlsmed?

Carlsmed (NASDAQ:CARL) and NeurAxis (NASDAQ:NRXS) are both small-cap medical equipment companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, profitability, analyst recommendations, valuation, risk, dividends, media sentiment and institutional ownership.

NeurAxis has lower revenue, but higher earnings than Carlsmed. NeurAxis is trading at a lower price-to-earnings ratio than Carlsmed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Carlsmed	$56.44M	4.91	-$29.63M	-$2.51	N/A
NeurAxis	$4.28M	20.39	-$14.63M	-$0.81	N/A

In the previous week, Carlsmed had 1 more articles in the media than NeurAxis. MarketBeat recorded 1 mentions for Carlsmed and 0 mentions for NeurAxis. Carlsmed's average media sentiment score of 1.89 beat NeurAxis' score of 0.00 indicating that Carlsmed is being referred to more favorably in the media.

Company	Overall Sentiment
Carlsmed	Very Positive
NeurAxis	Neutral

11.8% of NeurAxis shares are held by institutional investors. 21.1% of NeurAxis shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Carlsmed has a net margin of -57.76% compared to NeurAxis' net margin of -492.76%. NeurAxis' return on equity of 0.00% beat Carlsmed's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Carlsmed	-57.76%	-60.74%	-29.84%
NeurAxis	-492.76%	N/A	-641.25%

Carlsmed presently has a consensus price target of $19.33, suggesting a potential upside of 89.73%. NeurAxis has a consensus price target of $13.00, suggesting a potential upside of 84.45%. Given Carlsmed's higher possible upside, analysts plainly believe Carlsmed is more favorable than NeurAxis.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Carlsmed	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
NeurAxis	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Summary

NeurAxis beats Carlsmed on 8 of the 15 factors compared between the two stocks.

How does NeurAxis compare to Electromed?

NeurAxis (NASDAQ:NRXS) and Electromed (NYSE:ELMD) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, profitability, institutional ownership, dividends, risk, earnings, analyst recommendations and valuation.

NeurAxis has a beta of 1.42, suggesting that its stock price is 42% more volatile than the broader market. Comparatively, Electromed has a beta of 0.53, suggesting that its stock price is 47% less volatile than the broader market.

11.8% of NeurAxis shares are held by institutional investors. Comparatively, 40.8% of Electromed shares are held by institutional investors. 21.1% of NeurAxis shares are held by company insiders. Comparatively, 10.5% of Electromed shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Electromed has a net margin of 11.34% compared to NeurAxis' net margin of -492.76%. Electromed's return on equity of 15.71% beat NeurAxis' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
NeurAxis	-492.76%	N/A	-641.25%
Electromed	11.34%	15.71%	13.37%

Electromed has higher revenue and earnings than NeurAxis. NeurAxis is trading at a lower price-to-earnings ratio than Electromed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NeurAxis	$4.28M	20.39	-$14.63M	-$0.81	N/A
Electromed	$71.75M	4.16	$5.15M	$1.17	30.82

In the previous week, Electromed's average media sentiment score of 1.00 beat NeurAxis' score of 0.00 indicating that Electromed is being referred to more favorably in the news media.

Company	Overall Sentiment
NeurAxis	Neutral
Electromed	Positive

NeurAxis currently has a consensus price target of $13.00, suggesting a potential upside of 84.45%. Electromed has a consensus price target of $37.50, suggesting a potential upside of 4.01%. Given NeurAxis' higher possible upside, equities research analysts plainly believe NeurAxis is more favorable than Electromed.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NeurAxis	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Electromed	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	3.25

Summary

Electromed beats NeurAxis on 12 of the 16 factors compared between the two stocks.

How does NeurAxis compare to Shoulder Innovations?

Shoulder Innovations (NYSE:SI) and NeurAxis (NASDAQ:NRXS) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, media sentiment, profitability, institutional ownership, earnings and risk.

Shoulder Innovations has a net margin of -81.78% compared to NeurAxis' net margin of -492.76%. NeurAxis' return on equity of 0.00% beat Shoulder Innovations' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Shoulder Innovations	-81.78%	-35.11%	-20.58%
NeurAxis	-492.76%	N/A	-641.25%

11.8% of NeurAxis shares are owned by institutional investors. 29.0% of Shoulder Innovations shares are owned by insiders. Comparatively, 21.1% of NeurAxis shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

In the previous week, Shoulder Innovations had 2 more articles in the media than NeurAxis. MarketBeat recorded 2 mentions for Shoulder Innovations and 0 mentions for NeurAxis. Shoulder Innovations' average media sentiment score of 0.00 equaled NeurAxis'average media sentiment score.

Company	Overall Sentiment
Shoulder Innovations	Neutral
NeurAxis	Neutral

NeurAxis has lower revenue, but higher earnings than Shoulder Innovations. NeurAxis is trading at a lower price-to-earnings ratio than Shoulder Innovations, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Shoulder Innovations	$47.32M	5.94	-$40.36M	-$166.96	N/A
NeurAxis	$4.28M	20.39	-$14.63M	-$0.81	N/A

Shoulder Innovations presently has a consensus target price of $21.00, indicating a potential upside of 54.91%. NeurAxis has a consensus target price of $13.00, indicating a potential upside of 84.45%. Given NeurAxis' stronger consensus rating and higher probable upside, analysts plainly believe NeurAxis is more favorable than Shoulder Innovations.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Shoulder Innovations	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57
NeurAxis	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Summary

Shoulder Innovations and NeurAxis tied by winning 7 of the 14 factors compared between the two stocks.

Get NeurAxis News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NRXS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

NRXS vs. The Competition

Export

Metric	NeurAxis	Electromedical equipment Industry	Medical Sector	NASDAQ Exchange
Market Cap	$87.56M	$70.49M	$6.26B	$12.43B
Dividend Yield	N/A	N/A	2.69%	5.29%
P/E Ratio	-3.84	8.14	22.42	24.23
Price / Sales	20.39	193.39	548.01	125.38
Price / Cash	N/A	41.36	42.31	57.88
Price / Book	-26.10	5.12	9.82	6.71
Net Income	-$14.63M	-$5.50M	$3.56B	$337.09M
7 Day Performance	-5.40%	-6.26%	-1.17%	0.63%
1 Month Performance	-12.77%	-9.82%	3.71%	5.15%
1 Year Performance	154.44%	154.65%	27.28%	34.36%

NeurAxis Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
NRXS NeurAxis	2.5382 of 5 stars	$7.05 +0.5%	$13.00 +84.4%	+159.6%	$87.56M	$4.28M	N/A	19
CLPT ClearPoint Neuro	3.0477 of 5 stars	$11.50 -2.7%	$18.00 +56.5%	+4.9%	$354.48M	$36.97M	N/A	110
CV CapsoVision	1.8993 of 5 stars	$6.74 +1.8%	$8.50 +26.1%	N/A	$330.76M	$13.55M	N/A	90
CARL Carlsmed	4.1726 of 5 stars	$11.72 -1.4%	$19.33 +65.0%	N/A	$323.23M	$50.51M	N/A	100	Positive News
ELMD Electromed	1.4052 of 5 stars	$38.26 -0.1%	$37.50 -2.0%	+79.5%	$316.79M	$71.75M	51.01	160	News Coverage Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:NRXS) was last updated on 6/3/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

NeurAxis (NRXS) Competitors

NRXS vs. CLPT, CV, CARL, ELMD, and SI

How does NeurAxis compare to ClearPoint Neuro?

Summary

How does NeurAxis compare to CapsoVision?

Summary

How does NeurAxis compare to Carlsmed?

Summary

How does NeurAxis compare to Electromed?

Summary

How does NeurAxis compare to Shoulder Innovations?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NRXS vs. The Competition

NeurAxis Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

NeurAxis (NRXS) Competitors

NRXS vs. CLPT, CV, CARL, ELMD, and SI

How does NeurAxis compare to ClearPoint Neuro?

Is NRXS or CLPT more profitable?

Do institutionals and insiders believe in NRXS or CLPT?

Do analysts recommend NRXS or CLPT?

Does the media prefer NRXS or CLPT?

Which has preferable valuation & earnings, NRXS or CLPT?

Which has more volatility & risk, NRXS or CLPT?

Summary

How does NeurAxis compare to CapsoVision?

Do insiders & institutionals have more ownership in NRXS or CV?

Do analysts recommend NRXS or CV?

Does the media favor NRXS or CV?

Which has preferable earnings & valuation, NRXS or CV?

Is NRXS or CV more profitable?

Summary

How does NeurAxis compare to Carlsmed?

Which has stronger valuation & earnings, CARL or NRXS?

Does the media favor CARL or NRXS?

Do institutionals & insiders hold more shares of CARL or NRXS?

Is CARL or NRXS more profitable?

Do analysts rate CARL or NRXS?

Summary

How does NeurAxis compare to Electromed?

Which has more risk & volatility, NRXS or ELMD?

Do institutionals and insiders have more ownership in NRXS or ELMD?

Is NRXS or ELMD more profitable?

Which has preferable valuation and earnings, NRXS or ELMD?

Does the media prefer NRXS or ELMD?

Do analysts recommend NRXS or ELMD?

Summary

How does NeurAxis compare to Shoulder Innovations?

Is SI or NRXS more profitable?

Do institutionals and insiders believe in SI or NRXS?

Does the media favor SI or NRXS?

Which has better valuation and earnings, SI or NRXS?

Do analysts prefer SI or NRXS?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NRXS vs. The Competition

NeurAxis Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools